RXMD Looking beyond technicals to fundamentals
Hi Big Tuna,
Congratulations - you're a grandparent! (If I haven't expressed that, already)
Hey, I understand how busy you are. I'm glad you had time to take a snapshot of RXMD, and I appreciate your chart TA summary! It will sure be interesting to see how it goes this week since I'm already in long on RXMD. I've been adding around the bottom at each step and run since early October after my initial position in early September.
RXMD reached a significant prior resistance level in December where you noted the most recent of a series of moon shots above the upper bollie, and has since been in a consolidation mode with low volume trading. The RSI has reset and is now in the 50 range. Considering the bounce from the MA50 on Friday which you also noted, it is possible that RXMD is starting the breakout for continuation of the upward price correction. I'm looking for confirmation on that this week.
Looking beyond the technicals to fundamentals, it should be easy to see that RXMD is greatly undervalued.(Would be interesting to hear others' comments on this - am I wrong? I just don't know of many - any? - other penny stocks that are so strong with all information available in reports, frequent management communication/updates and solid IR responsiveness: Questions? call IR at 786-657-2060 talk with Armen; leave a message if no answer... you'll get a call back)
Progressive Care has broken strongly out of the startup stage as a unique health services business and is strategically positioning its wholly owned subsidiary PharmCo as an upcoming national brand - expanding the market and customer base in south Florida, and this year looking to expand upward into the eastern coastal states through acquisition.
The company is now profitable and has cleared all debt from the balance sheet in 2015. Debt was accumulated from initial founding in 2007 through 2014, while building a strong core business and consistently increasing year over year revenue, to the current level of ~$15M (annualized).
The company is currently at $15M net sales with a market cap of only $6.65M. Part of this is due to a previously depressed pps while the stock was being diluted to pay down the debt, in combination with the prior "OTC Pink Limited Info" status (yield sign on OTC Markets). A price correction is ongoing since the "zero debt" milestone in December, and the yield sign was removed just last week on Jan 8 as RXMD was upgraded to "Current Information."
The COO was just promoted to CEO after a solid performance as COO, and will be agressively pursuing the vision of PharmCo as a national brand through 2016 and beyond.
As a profitable business in a high-demand, high-growth, high-margin market with zero debt and a flawless record of QoQ and YoY revenue growth over the past 3 years, Progressive Care is well-positioned to replicate the PharmCo "franchise" model to achieve this national PharmCo brand vision.
Progressive Care, Inc. (RXMD)
SHARE STRUCTURE & CAPITALIZATION
Share Price: $0.0189 (1/8/2016)
Market Cap: $6.65M with PPS = 0.0189 (1/8/2016)
Authorized Shares: 500,000,000
Shares Outstanding: 352,043,045
Insider Shares: 45,209,107
Float Shares: 306,833,938
REVENUE & DEBT
Revenue: $15.6M (annualized, based on Nov2015 revenue of ~$1.3M - latest PR'd revs)
YoY and QoQ revenue consistently increasing by 20-30% over past 3 years
Total Debt: $25k (only debt is note kept on record for holder that cannot be reached - may be deceased )
Convertible Debt: $0
INVESTOR RELATIONS CONTACT
901 N Miami Beach Blvd
Ste 1-2
North Miami Beach, FL 33162
786-657-2060
investors@progressivecareus.com
TRANSFER AGENT
Computershare
8742 Lucent Blvd
Suite 225
Highlands Ranch, CO 80129
303-262-0678
Hi Big Tuna,
Congratulations - you're a grandparent! (If I haven't expressed that, already)
Hey, I understand how busy you are. I'm glad you had time to take a snapshot of RXMD, and I appreciate your chart TA summary! It will sure be interesting to see how it goes this week since I'm already in long on RXMD. I've been adding around the bottom at each step and run since early October after my initial position in early September.
RXMD reached a significant prior resistance level in December where you noted the most recent of a series of moon shots above the upper bollie, and has since been in a consolidation mode with low volume trading. The RSI has reset and is now in the 50 range. Considering the bounce from the MA50 on Friday which you also noted, it is possible that RXMD is starting the breakout for continuation of the upward price correction. I'm looking for confirmation on that this week.
Looking beyond the technicals to fundamentals, it should be easy to see that RXMD is greatly undervalued.(Would be interesting to hear others' comments on this - am I wrong? I just don't know of many - any? - other penny stocks that are so strong with all information available in reports, frequent management communication/updates and solid IR responsiveness: Questions? call IR at 786-657-2060 talk with Armen; leave a message if no answer... you'll get a call back)
Progressive Care has broken strongly out of the startup stage as a unique health services business and is strategically positioning its wholly owned subsidiary PharmCo as an upcoming national brand - expanding the market and customer base in south Florida, and this year looking to expand upward into the eastern coastal states through acquisition.
The company is now profitable and has cleared all debt from the balance sheet in 2015. Debt was accumulated from initial founding in 2007 through 2014, while building a strong core business and consistently increasing year over year revenue, to the current level of ~$15M (annualized).
The company is currently at $15M net sales with a market cap of only $6.65M. Part of this is due to a previously depressed pps while the stock was being diluted to pay down the debt, in combination with the prior "OTC Pink Limited Info" status (yield sign on OTC Markets). A price correction is ongoing since the "zero debt" milestone in December, and the yield sign was removed just last week on Jan 8 as RXMD was upgraded to "Current Information."
The COO was just promoted to CEO after a solid performance as COO, and will be agressively pursuing the vision of PharmCo as a national brand through 2016 and beyond.
As a profitable business in a high-demand, high-growth, high-margin market with zero debt and a flawless record of QoQ and YoY revenue growth over the past 3 years, Progressive Care is well-positioned to replicate the PharmCo "franchise" model to achieve this national PharmCo brand vision.
Progressive Care, Inc. (RXMD)
SHARE STRUCTURE & CAPITALIZATION
Share Price: $0.0189 (1/8/2016)
Market Cap: $6.65M with PPS = 0.0189 (1/8/2016)
Authorized Shares: 500,000,000
Shares Outstanding: 352,043,045
Insider Shares: 45,209,107
Float Shares: 306,833,938
REVENUE & DEBT
Revenue: $15.6M (annualized, based on Nov2015 revenue of ~$1.3M - latest PR'd revs)
YoY and QoQ revenue consistently increasing by 20-30% over past 3 years
Total Debt: $25k (only debt is note kept on record for holder that cannot be reached - may be deceased )
Convertible Debt: $0
INVESTOR RELATIONS CONTACT
901 N Miami Beach Blvd
Ste 1-2
North Miami Beach, FL 33162
786-657-2060
investors@progressivecareus.com
TRANSFER AGENT
Computershare
8742 Lucent Blvd
Suite 225
Highlands Ranch, CO 80129
303-262-0678
